Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RAR'alfa' (2004)
- Authors:
- Autor USP: REGO, EDUARDO MAGALHAES - FMRP
- Unidade: FMRP
- DOI: 10.1038/sj.onc.1207073
- Assunto: ONCOGENES
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SUKHAI, Mahadeo et al. Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RAR'alfa'. Oncogene, v. 23, p. 665-678, 2004Tradução . . Disponível em: https://doi.org/10.1038/sj.onc.1207073. Acesso em: 02 dez. 2025. -
APA
Sukhai, M., Wu, X., Xuan, Y., Zhang, T., Reis, P. P., Dubé, K., et al. (2004). Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RAR'alfa'. Oncogene, 23, 665-678. doi:10.1038/sj.onc.1207073 -
NLM
Sukhai M, Wu X, Xuan Y, Zhang T, Reis PP, Dubé K, Rego EM, Bhaumik M, Bailey DJ, Kamel-Reid S, Pandolfi PP, Wells RA. Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RAR'alfa' [Internet]. Oncogene. 2004 ; 23 665-678.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1038/sj.onc.1207073 -
Vancouver
Sukhai M, Wu X, Xuan Y, Zhang T, Reis PP, Dubé K, Rego EM, Bhaumik M, Bailey DJ, Kamel-Reid S, Pandolfi PP, Wells RA. Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RAR'alfa' [Internet]. Oncogene. 2004 ; 23 665-678.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1038/sj.onc.1207073 - Trangenic mice expressing hCG-NuMA-RAR'alfa' develop hematopoietic abnormalities leading to acute promyelocytic leukemia
- Role od promyelocytic leukemia (PML) protein in tumor suppression
- Estudo da relevância da inativação do CCAAT enhancer binding protein 'alfa' (C/EBP'alfa') na gênese da leucemia promielocítica
- Linfomas não Hodgkin de células T maduras e de células NK extramodais
- Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
- Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
- Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
- Anemia e palidez
- Temporal trends in Hematopoietic Stem Cell Transplantation in Argentina. [Editorial]: regional differences that mirror the global reality
Informações sobre o DOI: 10.1038/sj.onc.1207073 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
